The In Vitro Diagnostics Enzymes market size is expected to reach $3.25 billion in 2030 at a CAGR of 7.0%, driven by rising cancer prevalence.
Read More
The In Silico Protein Design market size is expected to reach $4.86 billion in 2030 at a CAGR of 20.9%, driven by personalized medicine demand.
Read More
The Immunotoxin market size is expected to reach $96.77 billion in 2030 at a CAGR of 7.8%, driven by breast cancer incidence.
Read More
Immunosuppressants Market Performance Outlook 2026–2030: Revenue to Hit $62.64 Billion at 13.1% CAGR
The Immunosuppressants market size is expected to reach $62.64 billion in 2030 at a CAGR of 13.1%, driven by autoimmune disease rise.
Read More
The Immuno-Oncology Drugs market size is expected to reach $226.31 billion in 2030 at a CAGR of 13.5%, driven by rising cancer incidence.
Read More
The Immunology Biosimilars market size is expected to reach $15.3 billion in 2030 at a CAGR of 12.8%, driven by chronic immune conditions.
Read More
The Immunohematology market size is expected to reach $3.27 billion in 2030 at a CAGR of 5.0%, driven by aging population growth.
Read More
The Immunoglobulins market size is expected to reach $34.52 billion in 2030 at a CAGR of 11.3%, driven by rising healthcare expenditure.
Read More
The Immunoglobulin Fusion Protein market size is expected to reach $87.21 billion in 2030 at a CAGR of 13.6%, driven by autoimmune disorders.
Read More
The Hepatitis B Virus (HBV) Capsid Inhibitors market size is expected to reach $0.98 billion in 2030 at a CAGR of 13.4%, driven by rising HBV infections.
Read More